In focus · trending topic

Dr. Lui Franciosi

8 stories · following the connections

Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

By Nasdaq OMXMar 21, 2018, 7:15 AM UTC

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

By Nasdaq OMXFeb 20, 2018, 8:10 AM UTC

Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

By Nasdaq OMXJan 4, 2018, 11:14 PM UTC

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

By Nasdaq OMXDec 28, 2017, 8:05 AM UTC

Veritas’ Research Arm Cannevert Signs a Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico

By Nasdaq OMXDec 5, 2017, 8:05 AM UTC

Veritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing Facility

By Nasdaq OMXNov 18, 2017, 9:44 PM UTC

Veritas Pharma Initiates Cancer Research with Dr. Dmitri Petchkovski

By Nasdaq OMXNov 14, 2017, 9:15 PM UTC

Veritas and Cannevert Hires the Essèntium Group as Their Agent in Puerto Rico USA

By Nasdaq OMXNov 13, 2017, 8:05 AM UTC